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Background & objectives: Perforin is one of the major effector molecules of cytotoxic cells associated
with killing of cells harbouring intracellular bacterial infection. The precise role of perforin positive
cells in tuberculosis still remains controversial. The present study was done to determine the number
of circulating CD4+ and CD8+ perforin positive cells to assess the level of cytotoxic response against
Mycobacterium tuberculosis in patients with pulmonary tuberculosis.
Methods: Intracellular perforin and surface CD4 and CD8 staining of peripheral blood lymphocytes
was done using specific monoclonal antibodies and enumerated using flowcytometry.
Results: A significantly decreased total lymphocytes (P<0.01), CD4 (P<0.001) and CD8 (P<0.01)
lymphocyte counts in PTB patients was observed compared to normal healthy individuals (NHS).
Intracellular perforin staining showed significantly elevated percentages of total (P<0.05) and CD8
(P<0.01) perforin positive cells in PTB patients compared to NHS. However, the absolute counts of
total, CD4 and CD8 cells positive for perforin were similar in patients and NHS.
Interpretation & conclusion: Our results suggest that during active stage of pulmonary tuberculosis
there was an increased percentage of CD8 cells positive for perforin, irrespective of their absolute
counts. Further, CD8+ perforin positive cells may have increased cytolytic activity against M.
tuberculosis in active pulmonary tuberculosis.
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Mycobacterium tuberculosis, the most successful
intracellular pathogen accounts for more deaths
worldwide than any other infectious pathogen1. Very
few pathogens induce a broad spectrum of immune
response as M. tuberculosis.  Effective immunity to
intracellular bacterial infection often requires the
lysis of infected cells as well as killing of the
pathogen. The role of cytotoxic cells is appreciated
in other intracellular bacterial infections such as
Listeria monocytogenes but its precise role in
tuberculosis remains controversial2,3. It is postulated
that lysis of infected macrophages could facilitate
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the translocation of M. tuberculosis  from
incapacitated cells to more proficient effector cells4.
Perforin is a 70 kDa pore forming glycoprotein
stored and released by the lytic granules of cytotoxic
killer cells [CD8 cells, natural killer (NK) cells,
cytotoxic CD4 cells and gd-T cells] on the target cell
membrane. Infected target macrophages are lysed by
the granule mediated perforin mechanism of
apoptosis that co-deliver bactericidal proteins like
granulysin5. It is shown that lysis of infected human
dendritic cells and macrophages by CD8 cells
specific for M. tuberculosis antigen reduced the
intracellular bacterial numbers and the killing was
perforin dependent6,7.
The present study was aimed to delineate the level
of CD4 and CD8 positive perforin positive cells to
understand the cytolytic activity against M.
tuberculosis in patients with pulmonary tuberculosis
(PTB).
Material & Methods
The present study is part of a major ongoing
project,  cleared by the Institutional Ethical
Committee. During the study period (January - May
2004), 30 pulmonary tuberculosis patients (mean age
+ SE: 30.6 + 1.2 yr) attending Tuberculosis Research
Centre, Chennai, and 25 normal healthy volunteers
who were willing to participate in the study were
included. The patients with respiratory symptoms and
radiographic abnormalities suggestive of pulmonary
tuberculosis were confirmed by sputum positivity for
M. tuberculosis by both smear and culture. All were
HIV negative and studied before the commencement
of anti-tuberculosis drug treatment. Informed consent
was obtained from each patient before the collection
of blood sample. Of the 30 patients included, 20 were
males and 10 were females. The normal healthy group
(17 males, 8 femals, mean age + SE 25.9 + 1.7 yr)
included the volunteers who were clinically normal
and free from viral diseases at the time of blood
sample collection.
Peripheral blood was obtained by venipuncture.
About 0.5 ml of blood was heparinized and used for
haematological profile using electron profile counter
(ABX micros CE Haematalgie, France), intracellular
perforin, CD4 and CD8 staining.
Flowcytometric detection of intracellular perforin
in whole blood was performed as described earlier8.
The leucocytes of the heparinized blood (75 µl) were
stained for surface CD4 or CD8 antigens using
fluorescein isothiocyanate (FITC) conjugated
antibody (Becton-Dickinson, USA). CD16 staining
was also done in four normal healthy subjects. Red
blood cells (RBC) were then lysed with RBC lysis
solution (Becton-Dickinson, USA). The leucocytes
were fixed in 4 per cent paraformaldehyde for
10 min and permeabilized at 4oC for 10 min with
cold phosphate buffered saline (PBS) containing
1 per cent foetal calf serum (FCS) and 0.1 per cent
saponin. Intracellular perforin staining was
performed by incubating the cells with phycoerythrin
(PE) or FITC labeled perforin antibody (Becton
Dickinson, USA) at 4oC for 30 min. Stained cells
were washed twice in cold PBS and then acquired in
Becton Dickinson FACSort flowcytometer and
analysed using ‘Cell Quest Pro’ Software. By scatter
pattern, 10,000 gated events in the lymphogate were
counted.
Student’s ‘t’ test was performed using ‘Microsoft
Excel 2000’ software to find the significance of
perforin positive cell numbers between the two
study groups.
Results & Discussion
Significant decrease in total lymphocytes
(P<0.01) and total CD4+ (P<0.001) and CD8+ cell
(P<0.01) count was observed in PTB patients
compared to normal healthy subjects (NHS). The
absolute number of perforin positive total CD4, CD8
and CD4/CD8 double negative cells were similar in
both PTB patients and NHS (Fig. A).
However, a significantly increased percentage of
total perforin positive cells and CD8 perforin positive
cells was observed in PTB patients as compared to
NHS [Total: 24.5 + 1.7 vs 20.7 + 1.2%, (P<0.05);
CD8: 12.7 + 2.3 vs 9.4 + 0.6%, (P <0.01)]. No major
difference in the percentage of perforin positive CD4
and CD4/CD8 double negative cells was seen in the
two groups (Fig. B).
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CD8+ cytolytic T-lymphocytes have been
implicated in protective immune response against
human tuberculosis.  In the present study,
significantly increased percentage of total perforin
positive cells and CD8 perforin positive cells was
observed in PTB patients compared to NHS.
Although a significant increase in percentage of
perforin positive CD8 cells was observed in patients,
no difference in the absolute number of perforin
positive lymphocytes in peripheral blood was seen
due to decrease in the number of lymphocytes in PTB
patients. This suggests that the cytolytic granules of
CD8+ and to certain extent CD4+ cells are activated
in pulmonary tuberculosis, by live M. tuberculosis
and their antigenic components. Human in vitro
studies have shown that CD8+ T cells become
activated and show cytolytic activity when stimulated
with live M. bovis  BCG and M. tuberculosis
H37Rv9,10. A study carried out in Gambian population
reported an increase in CD8+ T cell activation and
perforin production in response to M. tuberculosis
H37Ra in normals when compared to tuberculosis
patients11.
CD4/CD8 double negative cells positive for
perforin are predominantly natural killer (NK) cells12.
However, CD4/CD8 double negative cells also
include gd T cells that also show natural killer activity
similar to NK cells and express perforin. About
1-5 per cent of peripheral T cells are gd cells. CD16
is a surface marker present on both NK cells and gd
T cells and is a component of Fcg R-III which
mediates antibody dependent cell cytotoxicity. An
increase in NK cell (CD16/56) number has been
reported earlier in pulmonary tuberculosis13.
However, in the present study, we observed no
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Fig.(A). Absolute counts of lymphocytes per microlitre in the peripheral blood of normals (NHS) and patients (PTB). Total lymphocytes
(P<0.01*), perforin positive cells, CD4+ cells (P=0.001**), CD8+ cells (P<0.01#) CD8 perforin double positive cells, CD 16 perforin
double positive cells. B. Immunophenotype of perforin positive cells among peripheral blood white cells in NHS and PTB. Significantly
increased percentage of total perforin positive cells (P<0.05*), and CD8+ perforin+ cells (P=0.01**) was observed in PTB when
compared to NHS. Results are expressed as mean + SE.
significant increase in CD4/CD8 double negative
cells expressing perforin in PTB patients, a majority
of which are NK cells. Earlier reports show that NK
cells respond to M. tuberculosis infection but play a
minimal role in protection14.
In the present study, the observed increase in
percentage of perforin positive cells of PTB patients
may be due to perforin producing CD8 cells rather
than NK cells or gd T cells. Thus, in spite of decrease
in the absolute number of CD8+ cells, there was no
decrease in total and CD8+ cells expressing perforin
in PTB patients. The present study suggests that
higher percentage of circulating perforin positive
CD8 cells in patients may serve as an evidence for
the activation of acquired immune response and the
cytolytic role played by CD8+ lymphocytes against
M. tuberculosis in vivo.
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